Neogen CORP Form 4 insider transactions

NEOGEN's Chief Legal Officer, Amy M. Rocklin, acquired 119,705 shares of common stock and 307,680 stock options as part of equity compensation.

NEOGEN's Chief Accounting Officer, John Patrick Moylan, acquired 18,416 shares of common stock and 47,336 derivative securities, likely options or RSUs, effective August 15, 2025.

NEOGEN CEO Mikheal Nassif reported the acquisition of over 2.1 million shares and derivative securities, including options and restricted stock units, through grants with future vesting schedules.

NEOGEN Corporation's Director, Andrea F. Wainer, acquired 6,090 shares of common stock and 16,303 derivative securities (options/RSUs) on June 2, 2025, signaling increased insider ownership.

NEOGEN's Chief Financial Officer, David H. Naemura, has reported the acquisition of 52,724 shares of common stock and 211,723 derivative securities (rights to buy common stock) at an exercise price of $5.69 per share, indicating a substantial increase in his beneficial ownership.

Amy M. Rocklin, Chief Legal Officer of NEOGEN CORP, reported the acquisition of 43,585 shares of common stock and 175,024 derivative securities, likely options or RSUs, on June 2, 2025, signaling increased insider ownership.

NEOGEN Corp.'s Chief Accounting Officer, John Patrick Moylan, has acquired 26,362 shares of common stock and 70,574 derivative securities, signaling confidence in the company's future.

Director Aashima Gupta purchased 16,000 shares of Neogen Corp common stock at $6.2492 per share on May 12, 2025.

John Patrick Moylan, Chief Accounting Officer of Neogen Corp, exercised stock options and sold shares on May 1, 2025.

Neogen CEO John Edward Adent exercised restricted stock units (RSUs) on April 28, 2025, converting them into common stock.

Douglas Edward Jones, Chief Operating Officer of Neogen Corp, reports the vesting and settlement of restricted stock units (RSUs) resulting in the acquisition and disposal of common stock.

Amy M. Rocklin, Chief Legal Officer of Neogen Corp, reports the vesting and settlement of restricted stock units (RSUs) into common stock on April 28, 2025.

Director Catherine E Woteki purchased 5,770 shares of Neogen Corp stock at $5.17 per share on April 25, 2025.

Director James C. Borel purchased 30,000 shares of Neogen Corp stock at $4.99 per share on April 24, 2025.

Director William T Boehm purchased 5,000 shares of Neogen Corp common stock at $5.235 per share on April 24, 2025, increasing his total holdings to 36,214 shares.

Director James C Borel purchased 35,000 shares of Neogen Corp common stock at $4.894 per share on April 24, 2025.

Amy M Rocklin, Chief Legal Officer of Neogen Corp, recently purchased 12,500 shares of common stock at $4.99 per share.

Jeffrey D. Capello, a director at Neogen Corp, purchased 20,712 shares of common stock at $4.8386 per share on April 22, 2025.

Director James P. Tobin of Neogen Corp. purchased 10,000 shares of common stock at $4.7268 per share on April 22, 2025.

Director Rafael Rodriguez reported acquiring 7,474 shares of Neogen Corp common stock at $4.59 per share on April 22, 2025.

Chief Accounting Officer John Patrick Moylan reports purchasing 10,000 shares of Neogen Corp common stock at $5.07 per share on April 10, 2025.

Neogen Corp's CFO, David H. Naemura, acquired 10,034 shares of common stock and 45,150 stock options on January 16, 2025.

Neogen Corp's CFO, David H. Naemura, purchased 14,800 shares of common stock at a price of $11.11 per share on January 16, 2025.

Neogen CEO John Edward Adent purchased 23,035 shares of common stock at a price of $11.03 per share on January 16, 2025.

Neogen Corp's CFO, David H. Naemura, executed transactions involving common stock and restricted stock units on November 29, 2024.

Director Thierry Bernard reports acquisition of restricted stock units and options in Neogen Corp.

Director Catherine Woteki reported the vesting and settlement of Restricted Stock Units (RSUs) into common stock of Neogen Corp on October 28, 2024.

Director James P. Tobin of Neogen Corp reports the vesting and settlement of Restricted Stock Units (RSUs) into common stock on October 28, 2024.

Director Rafael A Rodriguez reported the vesting and settlement of restricted stock units (RSUs) into common stock of Neogen Corp on October 28, 2024.

Director Ronald D Green reported the vesting and settlement of Restricted Stock Units (RSUs) into common stock on October 28, 2024.